Diet-Induced Changes in Functional Disability among People with Multiple Sclerosis: A Secondary Pooled Analysis of Two Randomized Controlled Pilot Trials

Sclerosis Pub Date : 2024-07-04 DOI:10.3390/sclerosis2030011
Allison R. Groux, Elizabeth S. Walker, F. Shemirani, Jennifer E. Lee, Amanda K. Irish, Linda M Rubenstein, Linda G. Snetselaar, Warren G Darling, T. Wahls, Tyler J. Titcomb
{"title":"Diet-Induced Changes in Functional Disability among People with Multiple Sclerosis: A Secondary Pooled Analysis of Two Randomized Controlled Pilot Trials","authors":"Allison R. Groux, Elizabeth S. Walker, F. Shemirani, Jennifer E. Lee, Amanda K. Irish, Linda M Rubenstein, Linda G. Snetselaar, Warren G Darling, T. Wahls, Tyler J. Titcomb","doi":"10.3390/sclerosis2030011","DOIUrl":null,"url":null,"abstract":"Emerging evidence links dietary interventions to favorable multiple sclerosis (MS) outcomes; however, evidence for the efficacy of dietary interventions on functional disability remains sparse. Data from two 12-week, randomized, controlled pilot trials were pooled to investigate the efficacy of a modified Paleolithic diet (Paleo) on functional disability, as assessed by the MS Functional Composite (MSFC), among people diagnosed with MS. Pooled baseline-referenced MSFC scores were calculated from the nine-hole peg test (NHPT), timed 25-foot walk (T25FW), and Paced Auditory Serial Addition Test (PASAT) Z-scores. There was no significant difference in the mean change in MSFC scores between groups (p = 0.07). In the Paleo group, a significant increase was observed in the MSFC scores (p = 0.03), NHPT (p < 0.001), and PASAT (p = 0.04) Z-scores at 12 weeks, indicating reduced functional disability compared to baseline values. No significant changes were observed within the Control group. Study-specific differences in the MSFC changes between groups were observed. Functional disability was reduced compared to the baseline in the Paleo group, possibly depending on MS type. These results provide preliminary observations on the efficacy of a modified Paleolithic diet for reducing or maintaining functional disability in MS.","PeriodicalId":513065,"journal":{"name":"Sclerosis","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sclerosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/sclerosis2030011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Emerging evidence links dietary interventions to favorable multiple sclerosis (MS) outcomes; however, evidence for the efficacy of dietary interventions on functional disability remains sparse. Data from two 12-week, randomized, controlled pilot trials were pooled to investigate the efficacy of a modified Paleolithic diet (Paleo) on functional disability, as assessed by the MS Functional Composite (MSFC), among people diagnosed with MS. Pooled baseline-referenced MSFC scores were calculated from the nine-hole peg test (NHPT), timed 25-foot walk (T25FW), and Paced Auditory Serial Addition Test (PASAT) Z-scores. There was no significant difference in the mean change in MSFC scores between groups (p = 0.07). In the Paleo group, a significant increase was observed in the MSFC scores (p = 0.03), NHPT (p < 0.001), and PASAT (p = 0.04) Z-scores at 12 weeks, indicating reduced functional disability compared to baseline values. No significant changes were observed within the Control group. Study-specific differences in the MSFC changes between groups were observed. Functional disability was reduced compared to the baseline in the Paleo group, possibly depending on MS type. These results provide preliminary observations on the efficacy of a modified Paleolithic diet for reducing or maintaining functional disability in MS.
饮食对多发性硬化症患者功能障碍的影响:两项随机对照试验的二次汇总分析
新出现的证据表明,饮食干预与多发性硬化症(MS)的良好预后有关;然而,饮食干预对功能性残疾的疗效证据仍然稀少。我们汇总了两项为期 12 周的随机对照试验的数据,以研究改良旧石器时代饮食(Paleo)对已确诊多发性硬化症患者的功能性残疾的疗效,该疗效由多发性硬化症功能综合征(MSFC)评估。根据九孔钉测试(NHPT)、25英尺定时行走(T25FW)和步调听觉连续加法测试(PASAT)的Z分数计算出汇总的基线参考MSFC分数。组间 MSFC 评分的平均变化无明显差异(P = 0.07)。在 Paleo 组,12 周时的 MSFC 分数(p = 0.03)、NHPT(p < 0.001)和 PASAT(p = 0.04)Z-scores 均有明显增加,表明与基线值相比,功能障碍程度有所减轻。对照组没有观察到明显变化。各组之间的 MSFC 变化存在研究特异性差异。与基线值相比,Paleo 组的功能障碍有所减轻,这可能取决于多发性硬化症的类型。这些结果提供了关于改良旧石器时代饮食对减少或维持多发性硬化症功能障碍的有效性的初步观察。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信